TrialBMC infectious diseases2018

SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.

Alain Amstutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.